In a study of gemcitabine-resistant pancreatic cancer cells, apigenin combined with gemcitabine was found to block the cell cycle of drug-resistant cells, downregulate gemcitabine-induced p-Akt, and induce apoptosis in tumor cells [88]. The gene discussed is AKT1; the disease is neoplasm.